Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cytosorbents (CTSO) has issued an announcement.
CytoSorbents Corporation has appointed Peter J. Mariani as the new Chief Financial Officer starting August 14, 2024, following the retirement of Kathleen P. Bloch who will transition to a consulting role. Mariani, with over 25 years of experience in finance within the medical device sector, will receive a base salary of $425,000, potential bonuses, and various stock options and benefits as part of his employment agreement, which runs through December 31, 2025, with automatic renewals. Bloch’s consulting agreement will see her aiding in the CFO transition until the end of 2025 at a rate of $335 per hour.
For an in-depth examination of CTSO stock, go to TipRanks’ Stock Analysis page.
